Dr. Heptulla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Millennium Medical and Rehab
1075 Central Park Ave
Scarsdale, NY 10583Phone+1 914-472-2700
Education & Training
- Yale-New Haven Medical CenterFellowship, Pediatric Endocrinology, 1995 - 1998
- UMass Chan - BaystateResidency, Pediatrics, 1994 - 1995
- Brown UniversityResidency, Pediatrics, 1992 - 1994
- Maulana Azad Medical CollegeClass of 1990
- Jai Hind CollegeNo Degree, Science, 1985
Certifications & Licensure
- CT State Medical License 1995 - 2025
- NY State Medical License 2010 - 2025
- TX State Medical License 2002 - 2011
- MA State Medical License 1999 - 2010
- RI State Medical License 1992 - 1994
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2014-2015
- New York Magazine: Top Doctors Castle Connolly, 2013-2014
- Leading Physicians of the world 2013
- Join now to see all
Clinical Trials
- The Role of Amylin and Glucagon in T1DM Start of enrollment: 2002 Jul 01
- The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes Start of enrollment: 2003 Oct 01
- Ability to Cope With Type 1 Diabetes Start of enrollment: 2004 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 158 citationsSotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 DiabetesArthur T. Sands, Brian Zambrowicz, Julio Rosenstock, Pablo Lapuerta, Bruce W. Bode
Diabetes Care. 2015-07-01 - 298 citationsThe influence of insulin on circulating ghrelin.Daniel Flanagan, Mark L. Evans, Teresa P. Monsod, Frances Rife, Rubina A. Heptulla
American Journal of Physiology. Endocrinology and Metabolism. 2003-02-01 - 36 citationsRole of Glucagon-Like Peptide-1 Analogue Versus Amylin as an Adjuvant Therapy in Type 1 Diabetes in a Closed Loop Setting With ePID AlgorithmVenkat S Renukuntla, Neesha Ramchandani, Jeniece Trast, Martin Cantwell, Rubina A. Heptulla
Journal of Diabetes Science and Technology. 2014-07-16
Journal Articles
- Obesity, hyperglycemia and endothelial function in inner city Bronx adolescents: a cross-sectional studyAgarwal C, Cohen HW, Muzumdar RH, Heptulla RA, Renukuntla VS, Crandall J, Int J of Pediatric Endocrinol, 10/29/2013
- Diabetic neuropathic cachexia in an adolescent girl A rare case reportDeOrchis VS, Herskovitz S, Laureta E, Heptulla RA, Pediatric Neurology, 10/1/2013
- National Study of Continuity Clinic Satisfaction in Pediatric Fellowship TrainingGangat M, Klein G, Cohen H, Heptulla RA, Advances in Medical Education and Practice, 9/16/2013
- Join now to see all
Lectures
- Illness Identity and Self-Management of T1DM in AdolescentsBronx, NY - 6/15/2014
- Relationship of Self-Esteem to Glycemic Control amongst Minority Adolescents with Type 1 DiabetesBronx, NY - 6/15/2014
- Decreasing Pediatric Ketoacidosis Hospitalizations: A Successful QI InitiativeBronx, NY - 6/15/2014
Press Mentions
- Sweet Halloweens for Kids with Special Health NeedsOctober 29th, 2015
- Insulin Pump May Cut Risk of Heart Disease Deaths with DiabetesJuly 2nd, 2015
- Patient Wait Times for Appointments Cut by More Than 80 PercentJanuary 22nd, 2013
Grant Support
- Novel Glucagon Modulators And The Closed Loop SystemNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Pediatric Type 1 Diabetes: Intervention Trials With Glucagon SuppressorsNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Exenatide (BYETTA) VS Pramlintide (SYMLIN)National Center For Research Resources2010
- Detemir: Role In Type 1 DiabetesNational Center For Research Resources2009–2010
- Pediatric Type 1 Diabetes: Intervention Trials With Glucagon SuppressorsNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
- Novel Glucagon Modulators And The Closed Loop SystemNational Institute Of Diabetes And Digestive And Kidney Diseases2009
- Clinical Trial: The Role Of Exenatide In Type I Diabetes MellitusNational Center For Research Resources2008–2009
- Clinical Trial: Post-Meal Insulin Dosing With Adjuvant Pre-Meal Pramlintide In CNational Center For Research Resources2008
- Clinical Trial: Continuous Subcutaneous Infusion Of Pramlintide And Insulin: ANational Center For Research Resources2008
- Continuous Subcutaneous Infusion Of Pramlintide And Insulin: A Randomized DONational Center For Research Resources2007
- New Therapeutic Targets In Pediatric Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
- The Effect Of Prolonged Pramlintide Infusion In Pediatric DiabetesNational Center For Research Resources2005–2006
- Glucose Excursions: Role Of Amylin And GlucagonNational Center For Research Resources2004–2006
- Examining The Effect Of Mixing Pramlintide W/ Humalog In Type I DiabetesNational Center For Research Resources2005
- Prolonged Pramlintide Infusion In Pediatric DiabetesNational Center For Research Resources2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: